Pfizer Inc.PFENYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year earnings per share growth rate
Latest
-146.77%
↓ 125% vs avg
Percentile
P3
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
593.58%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -146.77% |
| Q3 2025 | 21.57% |
| Q2 2025 | -2.45% |
| Q1 2025 | 622.10% |
| Q4 2024 | -90.83% |
| Q3 2024 | 18692.86% |
| Q2 2024 | -99.24% |
| Q1 2024 | 192.44% |
| Q4 2023 | -40.71% |
| Q4 2023 | -202.79% |
| Q3 2023 | -58.07% |
| Q2 2023 | 10.65% |
| Q4 2022 | -42.24% |
| Q4 2022 | -12.81% |
| Q3 2022 | 25.93% |
| Q2 2022 | 131.98% |
| Q4 2021 | -58.46% |
| Q4 2021 | 40.42% |
| Q3 2021 | 18.61% |
| Q2 2021 | 473.47% |
| Q4 2020 | -42.38% |
| Q3 2020 | -57.93% |
| Q2 2020 | 3.85% |
| Q1 2020 | 1093.27% |
| Q4 2019 | -104.41% |
| Q3 2019 | 51.65% |
| Q2 2019 | 31.88% |
| Q1 2019 | 1085.71% |
| Q4 2018 | -110.00% |
| Q3 2018 | 6.06% |
| Q3 2018 | 10.00% |
| Q2 2018 | -70.87% |
| Q4 2017 | 329.17% |
| Q4 2017 | -7.69% |
| Q3 2017 | 0.00% |
| Q2 2017 | 300.00% |
| Q4 2016 | -40.91% |
| Q4 2016 | -33.33% |
| Q3 2016 | -32.65% |
| Q2 2016 | 1856.27% |